Table 1.
Cohorts of HLA-A*02:01 positive, HSV seropositive Symptomatic and Asymptomatic individuals enrolled in the study
| Subject-level Characteristic | All Subjects (n = 30) | ASYMP (n = 15) | SYMP (n = 15) | HSV (−) (n = 5) |
|---|---|---|---|---|
| Gender [no. (%)]: | ||||
| Female | 15 (50%) | 8 (53%) | 7 (47%) | 2 (40%) |
| Male | 15 (50%) | 7 (47%) | 8 (53%) | 3 (60%) |
| Race [no. (%)]: | ||||
| Caucasian | 21 (70%) | 11 (73%) | 10 (67%) | 4 (80%) |
| Non-Caucasian | 9 (35%) | 4 (27%) | 5 (33%) | 1 (20%) |
| Age [median (range) yr.]: | 40 (23–55) | 42 (26–55) | 39 (23–55) | 36 (28–45) |
| HSV status [no. (%)]: | ||||
| HSV-1-seropositive | 30 (100 %) | 15 (100%) | 15 (100%) | 0 |
| HSV-2-seropositive | 0 (0%) | 0 | 0 | 0 |
| HSV-1- & 2-seropositive | 0 (0%) | 0 | 0 | 0 |
| HSV-seronegative | 0 (0%) | 0 | 0 | 5 (100%) |
| EBV-seropositive | 12 (40%) | 6 (40%) | 6 (40%) | N/A |
| HLA [no. (%)] | ||||
| HLA-A*02:01-positive | 30 (100%) | 15 | 15 | 5 |
| HLA-A*02:01-negative | 0 (0%) | 0 | 0 | 0 |
| Herpes Disease Status [no. (%)] | ||||
| Asymptomatic (ASYMP) | 15 (50%) | N/A | N/A | N/A |
| Symptomatic (SYMP) | 15 (50%) |